dalteparin sodium · Pfizer · NDA 020287
Fragmin
Earliest generic entry, as listed · earliest of 9 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 12
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020287 · 001 · RLD | injectable, subcutaneous | 2,500IU/0.2ML (12,500IU/ML) | open |
| 020287 · 002 · discontinued | injectable, subcutaneous | 10,000IU/0.4ML (25,000IU/ML) | open |
| 020287 · 003 · RLD | injectable, subcutaneous | 5,000IU/0.2ML (25,000IU/ML) | open |
| 020287 · 004 · RLD | injectable, subcutaneous | 10,000IU/ML (10,000IU/ML) | open |
| 020287 · 005 · RLD | injectable, subcutaneous | 7,500IU/0.3ML (25,000IU/ML) | open |
| 020287 · 006 · RLD | injectable, subcutaneous | 95,000IU/3.8ML (25,000IU/ML) | open |
| 020287 · 007 · discontinued | injectable, subcutaneous | 95,000IU/9.5ML (10,000IU/ML) | open |
| 020287 · 008 · discontinued | injectable, injection | 7,500 IU/0.75ML | open |
| 020287 · 009 · RLD | injectable, subcutaneous | 12,500IU/0.5ML (25,000IU/ML) | open |
| 020287 · 010 · RLD | injectable, subcutaneous | 15,000IU/0.6ML (25,000IU/ML) | open |
| 020287 · 011 · RLD | injectable, subcutaneous | 18,000IU/0.72ML (25,000IU/ML) | open |
| 020287 · 012 · RLD | injectable, subcutaneous | 10,000IU/4ML (2,500IU/ML) | open |